This inventor holds 7 USPTO granted patents. Top assignee: Eastman-Kodak Company. Active years: 1985-1991.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1985-1991
Title: Gary E. Norton: Inventor of Analytical Elements for Clinical Testing.
Introduction
Gary E. Norton is an inventor associated with Rochester, New York, and Eastman Kodak Company. His patent work includes analytical elements and methods for measuring substances such as theophylline, creatinine, and creatine. His portfolio includes 7 patents.
Latest Patents
Norton’s listed patents describe analytical elements designed to support chemical assays.
“Analytical Element for Theophylline Determination Using Buffer in a …” describes an element and method for determining theophylline by measuring its inhibition of alkaline phosphatase activity. The assay operates at a pH of 9 or less. The element uses fluid-connected zones, with the enzyme and its substrate placed in separate zones. A subbing zone containing polyvinylpyrrolidone and a buffer helps maintain the required pH.
“Analytical Element and Method for the Determination of Creatinine or …” describes an element for measuring creatinine, creatine, or both. It combines creatinine amidohydrolase, creatine amidinohydrolase, and sarcosine oxidase with a leuco dye that produces a detectable dye in the presence of hydrogen peroxide and a peroxidative substance. The enzymes are arranged to control their effects on the dye, and the amount of dye formed at selected times can be used to determine the analytes.
Career Highlights
Norton’s described inventions focus on analytical elements that bring reagents together in a structured format for measurement. The patent descriptions emphasize assay design, enzyme activity, pH control, and detectable dye formation. His work is associated with Eastman Kodak Company.
Collaborations
Norton’s listed coworkers include Paul H. Frickey and Allen L. Thunberg. Their names provide context for the colleagues associated with his patent work.
Conclusion
Gary E. Norton’s patents reflect contributions to analytical testing through enzyme-based methods and carefully designed assay elements for determining clinically relevant compounds.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
